Treatment of High-Risk Sickle Cell Disease (SCD) With Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation With T-Cell Addback (IND 14359)
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.110
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2015
Authors
Publisher
Elsevier BV